Geode Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,190,676
| Closed | -$24M | – | 5002 |
|
|
2021
Q3 | $24M | Buy |
1,190,676
+2,981
| +0.3% | +$60.1K | ﹤0.01% | 1824 |
|
|
2021
Q2 | $44.3M | Buy |
1,187,695
+65,189
| +6% | +$2.43M | 0.01% | 1408 |
|
|
2021
Q1 | $28.7M | Buy |
1,122,506
+89,668
| +9% | +$2.29M | ﹤0.01% | 1642 |
|
|
2020
Q4 | $22.8M | Buy |
1,032,838
+88,359
| +9% | +$1.95M | ﹤0.01% | 1641 |
|
|
2020
Q3 | $17M | Buy |
944,479
+4,736
| +0.5% | +$85.2K | ﹤0.01% | 1634 |
|
|
2020
Q2 | $23.9M | Buy |
939,743
+107,414
| +13% | +$2.73M | 0.01% | 1379 |
|
|
2020
Q1 | $15.3M | Buy |
832,329
+47,399
| +6% | +$871K | ﹤0.01% | 1479 |
|
|
2019
Q4 | $17.3M | Buy |
784,930
+61,805
| +9% | +$1.36M | ﹤0.01% | 1656 |
|
|
2019
Q3 | $10.4M | Buy |
723,125
+12,412
| +2% | +$178K | ﹤0.01% | 1908 |
|
|
2019
Q2 | $11.2M | Buy |
710,713
+57,434
| +9% | +$905K | ﹤0.01% | 1870 |
|
|
2019
Q1 | $9.57M | Buy |
653,279
+98,322
| +18% | +$1.44M | ﹤0.01% | 1921 |
|
|
2018
Q4 | $5.93M | Buy |
554,957
+109,012
| +24% | +$1.17M | ﹤0.01% | 2117 |
|
|
2018
Q3 | $6.81M | Buy |
445,945
+144,434
| +48% | +$2.2M | ﹤0.01% | 2169 |
|
|
2018
Q2 | $3.69M | Buy |
301,511
+139,934
| +87% | +$1.71M | ﹤0.01% | 2512 |
|
|
2018
Q1 | $1.54M | Buy |
161,577
+69,840
| +76% | +$667K | ﹤0.01% | 2908 |
|
|
2017
Q4 | $828K | Hold |
91,737
| – | – | ﹤0.01% | 3173 |
|
|
2017
Q3 | $527K | Buy |
91,737
+9,047
| +11% | +$52K | ﹤0.01% | 3337 |
|
|
2017
Q2 | $262K | Sell |
82,690
-3,260
| -4% | -$10.3K | ﹤0.01% | 3587 |
|
|
2017
Q1 | $292K | Buy |
85,950
+444
| +0.5% | +$1.51K | ﹤0.01% | 3518 |
|
|
2016
Q4 | $246K | Buy |
85,506
+296
| +0.3% | +$852 | ﹤0.01% | 3546 |
|
|
2016
Q3 | $501K | Buy |
85,210
+74
| +0.1% | +$435 | ﹤0.01% | 3247 |
|
|
2016
Q2 | $255K | Sell |
85,136
-16,392
| -16% | -$49.1K | ﹤0.01% | 3492 |
|
|
2016
Q1 | $544 | Buy |
101,528
+1,371
| +1% | +$7 | ﹤0.01% | 3186 |
|
|
2015
Q4 | $1.19M | Buy |
100,157
+1,769
| +2% | +$21K | ﹤0.01% | 2808 |
|
|
2015
Q3 | $807K | Buy |
98,388
+4,859
| +5% | +$39.9K | ﹤0.01% | 2987 |
|
|
2015
Q2 | $1.3M | Buy |
93,529
+30,032
| +47% | +$419K | ﹤0.01% | 2761 |
|
|
2015
Q1 | $1.53M | Buy |
63,497
+7,292
| +13% | +$175K | ﹤0.01% | 2609 |
|
|
2014
Q4 | $925K | Buy |
56,205
+15,906
| +39% | +$262K | ﹤0.01% | 2895 |
|
|
2014
Q3 | $513K | Buy |
40,299
+5,919
| +17% | +$75.3K | ﹤0.01% | 3160 |
|
|
2014
Q2 | $775K | Buy |
34,380
+278
| +0.8% | +$6.27K | ﹤0.01% | 2947 |
|
|
2014
Q1 | $963K | Buy |
+34,102
| New | +$963K | ﹤0.01% | 2816 |
|